Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Math P G Leers"'
Autor:
Inge H Y Luu, Tim Frijns, Jacqueline Buijs, Jasenko Krdzalic, Martijn D de Kruif, Guy J M Mostard, Hugo Ten Cate, Remy J H Martens, Remy L M Mostard, Math P G Leers, Daan J L van Twist
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0283459 (2023)
BackgroundDiagnosing concomitant pulmonary embolism (PE) in COVID-19 patients remains challenging. As such, PE may be overlooked. We compared the diagnostic yield of systematic PE-screening based on the YEARS-algorithm to PE-screening based on clinic
Externí odkaz:
https://doaj.org/article/cce76ede75094506a8e8cebbf15f171d
Autor:
Stefan G. C. Mestrum, Norbert C. J. de Wit, Eline M. P. Cremers, Roosmarie J. M. Drent, Frans C. S. Ramaekers, Anton H. N. Hopman, Math P. G. Leers
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e804 (2022)
Externí odkaz:
https://doaj.org/article/b9e57974a5ba4b56be736fd375b52052
Autor:
Math P G Leers, Ruben Deneer, Guy J M Mostard, Remy L M Mostard, Arjen-Kars Boer, Volkher Scharnhorst, Frans Stals, Henne A Kleinveld, Dirk W van Dam
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0270548 (2022)
BackgroundCOVID-19 is an ongoing pandemic leading to exhaustion of the hospital care system. Our health care system has to deal with a high level of sick leave of health care workers (HCWs) with COVID-19 related complaints, in whom an infection with
Externí odkaz:
https://doaj.org/article/2ccbf8f0ee074b6eb456e0836874b566
Autor:
Stefan G. C. Mestrum, Roanalis B. Y. Vanblarcum, Roosmarie J. M. Drent, Bert T. Boonen, Wouter L. W. van Hemert, Frans C. S. Ramaekers, Anton H. N. Hopman, Math P. G. Leers
Publikováno v:
Cytometry Part A, 101(7), 552-563. Wiley
Recent developments in clinical flow cytometry allow the simultaneous assessment of proliferative and anti-apoptotic activity in the different hematopoietic cell lineages and during their maturation process. This can further advance the flow cytometr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35373986f8195a336bf7893aaace521
https://doi.org/10.1002/cyto.a.24558
https://doi.org/10.1002/cyto.a.24558
Publikováno v:
International journal of molecular sciences. 23(18)
Acute myeloid leukemia (AML) is a myeloid malignancy that is characterized by the accumulation of leukemic blast cells, which originate from hematopoietic stem cells that have undergone leukemic transformation and/or are more mature progenitors that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b03ac82968121cfee739d663667128
https://doi.org/10.3390/ijms231810529
https://doi.org/10.3390/ijms231810529
Publikováno v:
Blood Adv
Standardization of the detection and quantification of leukocyte differentiation markers by the EuroFlow Consortium has led to a major step forward in the integration of flow cytometry into classification of leukemia and lymphoma. In our opinion, thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51ac560146b6109da483429e2ded0c6
https://doi.org/10.1182/bloodadvances.2020004094
https://doi.org/10.1182/bloodadvances.2020004094
Autor:
Roosmarie J. M. Drent, Stefan G. C. Mestrum, Norbert C. J. de Wit, Math P. G. Leers, Anton H. N. Hopman, Frans C. S. Ramaekers
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:322-330
The proliferation marker Ki-67 is widely used within the field of diagnostic histopathology as a prognostic marker for solid cancers. However, Ki-67 is hardly used for prognostic and diagnostic purposes in flow cytometric analyses of hematologic neop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dcb5476ca9426adaca159a68b18e1f8
https://doi.org/10.1002/cyto.b.21946
https://doi.org/10.1002/cyto.b.21946
Autor:
Wouter T, Leijte, Nicolaas M M, Wagemaker, Tom D A, van Kraaij, Martijn D, de Kruif, Guy J M, Mostard, Math P G, Leers, Rémy L M, Mostard, Jacqueline, Buijs, Daan J L, van Twist
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 164
Hospitalization for corona virus disease 2019 (COVID-19) may be followed by complications after discharge. We aimed to evaluate mortality, readmission rate, and readmission characteristics after hospitalization with COVID-19.A retrospective cohort st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::315bdb6de89d6ae9c2a6d9c0b34935f7
https://pubmed.ncbi.nlm.nih.gov/33332036
https://pubmed.ncbi.nlm.nih.gov/33332036
Autor:
Stefan G C, Mestrum, Norbert C J, de Wit, Roosmarie J M, Drent, Anton H N, Hopman, Frans C S, Ramaekers, Math P G, Leers
Publikováno v:
Cytometry. Part B, Clinical Cytometry
The proliferation marker Ki‐67 is widely used within the field of diagnostic histopathology as a prognostic marker for solid cancers. However, Ki‐67 is hardly used for prognostic and diagnostic purposes in flow cytometric analyses of hematologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::697e4f5b3c3443ecc5f62d1ff0b17063
https://pubmed.ncbi.nlm.nih.gov/32857909
https://pubmed.ncbi.nlm.nih.gov/32857909
Autor:
Roosmarie J. M. Drent, Frans C. S. Ramaekers, Kelly P.H. Nies, Kim H.K. Lindelauf, Raisa Kraaijvanger, Ronald M.J. Rutten, Math P. G. Leers
Publikováno v:
Cytometry Part A. 93:1097-1105
Because of the proven prognostic value of Ki-67 as a proliferation marker in several types of solid cancers, our goal is to develop and validate a multiparameter flow cytometric assay for the determination of the Ki-67 expression in hemato-oncologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1ebc8bc8b98083b88d9a9d0370e3b22
https://doi.org/10.1002/cyto.a.23564
https://doi.org/10.1002/cyto.a.23564